Insulet Investors Face August Deadline in Securities Fraud Lawsuit
Investors who incurred significant financial losses holding Insulet Corporation stock now have until August 31, 2026, to apply for lead plaintiff status in an ongoing class action lawsuit. The litigation centers on allegations that the medical device manufacturer misled shareholders regarding the integrity of its internal safety protocols.






















